Cardio-Oncology: Bridging Cancer Therapy and Cardiovascular Protection in the Era of Precision Medicine
Abstract
The field of cardio-oncology is a service that is new and which integrates various disciplines to assist individuals with cardiac issues that may occur during the course of cancer development or during the administration of treatment. New cancer therapies have increased the chances of individuals living longer, though most of these therapies may result in heart disorders, such as cardiomyopathy, heart failure, arrhythmias, high blood pressure, and thromboembolic incidents. These issues can make both cancer outcomes and heart health worse. Cardio-oncology is the study of the hearts and blood vessels of people with cancer. Before treatment, it includes a full cardiovascular risk assessment. During treatment, it includes constant monitoring, quick detection of cardiotoxicity, and long-term cardiac care for cancer survivors. People who work in this field try to find a way to treat cancer while also keeping the heart safe. Some are oncologists, cardiologists, pharmacists, and other health care workers. Imaging tests are some of the most essential strategies, as they assist doctors in determining what is wrong, heart-protecting drugs as well as personalized treatment plans that are designed on a case-by- case basis. Pharmacists can help a lot, monitors of your medications, and ensures that they do not interact with other drugs and maximizes on therapy. The rules are increasing, yet much of the evidence remains grounded on what individuals concur on. This implies that we should have more good research that is forward looking. Cardio-oncology is quite crucial in ensuring that individuals with cancer live longer, safer, and better lives.
Fields of Study & Subjects
Chemotherapy-induced cardiotoxicity and mitigation
Cardiac tumors and thrombi
Cardiovascular Function and Risk Factors
Publication details
- Journal / source
- International Journal of Innovative Science and Research Technology (IJISRT)
- Pages
- 733–733
- Publication date
- 15 January 2026